Latest Breaking News On - உற்பத்தி ஆதரவு - Page 1 : comparemela.com

Charles River Acquires Cell and Gene Therapy CDMO Cognate for $875M Charles River Laboratories plans to acquire the cell and gene therapy contract development and manufacturing organization (CDMO) Cognate BioServices for approximately $875 million cash, in a deal that further expands the buyer’s activity in the fast-growing sector. [Cognate BioServices] February 18, 2021 Charles River Laboratories plans to acquire the cell and gene therapy contract development and manufacturing organization (CDMO) Cognate BioServices for approximately $875 million cash, in a deal that further expands the buyer’s activity in the fast-growing sector. [Cognate BioServices] Share Charles River Laboratories chairman, president, and CEO James C. Foster

United statesJamesc fosterCharles river biologics testing solutionsCharles river laboratoriesRiver laboratoriesCognate bioservicesNorth americaCharles riverBiologics testing solutionsManufacturing supportDistributed bioஒன்றுபட்டது மாநிலங்களில்சார்லஸ் நதி உயிரியல் சோதனை தீர்வுகள்சார்லஸ் நதி ஆய்வகங்கள்நதி ஆய்வகங்கள்அறிவாற்றல் உயிர் சேவைகள்